HARVARD MANAGEMENT CO INC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 277 filers reported holding ROYALTY PHARMA PLC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.8%.

Quarter-by-quarter ownership
HARVARD MANAGEMENT CO INC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q4 2021$138,080,000
-46.5%
3,464,990
-51.5%
12.96%
-14.3%
Q3 2021$258,143,000
-11.8%
7,142,8560.0%15.13%
-10.2%
Q2 2021$292,786,000
-37.4%
7,142,856
-33.3%
16.85%
-35.5%
Q1 2021$467,357,000
-36.4%
10,714,284
-27.1%
26.11%
-34.5%
Q4 2020$735,274,000
+19.0%
14,690,7800.0%39.88%
+17.3%
Q3 2020$618,041,000
-13.3%
14,690,7800.0%33.99%
-44.1%
Q2 2020$713,237,00014,690,78060.83%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$122,204,89747.65%
Vantage Consulting Group Inc 1,022,194$36,829,65020.91%
Indie Asset Partners, LLC 433,000$15,600,99018.22%
Overbrook Management Corp 578,783$20,853,5515.46%
Silicon Valley Community Foundation 1,032,320$37,194,4905.36%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,047,049$109,785,1754.64%
Geo Capital Gestora de Recursos Ltd 142,748$5,1433.81%
Renaissance Capital LLC 123,913$4,464,5853.31%
Rokos Capital Management LLP 1,106,813$40,077,6982.96%
Lagoda Investment Management, L.P. 101,500$3,657,0452.60%
View complete list of ROYALTY PHARMA PLC shareholders